Stay updated with breaking news from Oncoextra Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Knights of Columbus Asset Advisors LLC grew its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 2.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 71,842 shares of the medical research company’s stock after buying an additional 1,457 shares during […]
TD Asset Management Inc increased its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 19.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 419,870 shares of the medical research company’s stock after buying an additional 69,071 […]
William Blair restated their outperform rating on shares of Exact Sciences (NASDAQ:EXAS – Free Report) in a research note released on Monday morning, RTT News reports. A number of other research analysts have also weighed in on EXAS. The Goldman Sachs Group reduced their price objective on shares of Exact Sciences from $100.00 to $90.00 […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eighteen research firms that are covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average twelve-month price target […]
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eighteen analysts that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12 month target […]